Sedivention raises €800K Pre-Seed round
18 November 2024· Munich, Germany· health, medtech, biotech, b2b, deep_hardware
The fresh capital will be used to advance the first preclinical studies and product development.
Investors
LeadHigh-Tech Gründerfonds
Also participating
BioVariaAndré Burch
About Sedivention
Stage
Pre-Seed
Headquarters
Munich, Germany
Founded
2021
Team Size
6–20
Sectors
healthmedtechbiotechb2bdeep_hardware
Source: https://www.htgf.de/en/sedivention-pre-seed-funding-obesity-therapy/